Profil
Christopher Smith is currently a Director at Denteric Pty Ltd., a Director at Axelia Oncology Pty Ltd., and a Partner at Brandon Capital Partners Pty Ltd. He was also a Director at Paragen Bio Pty Ltd.
Postes actifs de Christopher Smith
| Sociétés | Poste | Début |
|---|---|---|
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Private Equity Investor | 01/01/2012 |
Denteric Pty Ltd.
Denteric Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops vaccines for treating and preventing severe periodontal disease | Directeur/Membre du Conseil | - |
Axelia Oncology Pty Ltd.
Axelia Oncology Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company aiming to transform the treatment of checkpoint insensitive cancers | Directeur/Membre du Conseil | - |
Anciens postes connus de Christopher Smith
| Sociétés | Poste | Fin |
|---|---|---|
Paragen Bio Pty Ltd.
Paragen Bio Pty Ltd. BiotechnologyHealth Technology Engages in developing drugs for treatment of autoimmune diseases | Directeur/Membre du Conseil | - |
Formation de Christopher Smith
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Paragen Bio Pty Ltd.
Paragen Bio Pty Ltd. BiotechnologyHealth Technology Engages in developing drugs for treatment of autoimmune diseases | Health Technology |
Denteric Pty Ltd.
Denteric Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops vaccines for treating and preventing severe periodontal disease | Commercial Services |
Axelia Oncology Pty Ltd.
Axelia Oncology Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company aiming to transform the treatment of checkpoint insensitive cancers | Health Technology |
















